DK1005342T3 - Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid - Google Patents

Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid

Info

Publication number
DK1005342T3
DK1005342T3 DK98920285T DK98920285T DK1005342T3 DK 1005342 T3 DK1005342 T3 DK 1005342T3 DK 98920285 T DK98920285 T DK 98920285T DK 98920285 T DK98920285 T DK 98920285T DK 1005342 T3 DK1005342 T3 DK 1005342T3
Authority
DK
Denmark
Prior art keywords
tizoxanide
nitazoxanide
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
DK98920285T
Other languages
Danish (da)
English (en)
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1005342(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Application granted granted Critical
Publication of DK1005342T3 publication Critical patent/DK1005342T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK98920285T 1997-05-07 1998-05-06 Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid DK1005342T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (1)

Publication Number Publication Date
DK1005342T3 true DK1005342T3 (da) 2003-03-24

Family

ID=27420362

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02002887T DK1222921T3 (da) 1997-05-07 1998-05-06 Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid
DK98920285T DK1005342T3 (da) 1997-05-07 1998-05-06 Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02002887T DK1222921T3 (da) 1997-05-07 1998-05-06 Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid

Country Status (35)

Country Link
EP (2) EP1222921B1 (es)
JP (1) JP3739802B2 (es)
KR (2) KR100426657B1 (es)
CN (2) CN1158074C (es)
AP (1) AP1103A (es)
AR (1) AR057242A2 (es)
AT (2) ATE281166T1 (es)
AU (1) AU740022B2 (es)
BG (2) BG109365A (es)
BR (1) BR9808722A (es)
CA (2) CA2418634C (es)
CZ (2) CZ298269B6 (es)
DE (2) DE69827417T2 (es)
DK (2) DK1222921T3 (es)
EA (2) EA002920B1 (es)
EE (1) EE04870B1 (es)
ES (2) ES2232687T3 (es)
GE (1) GEP20032970B (es)
HK (1) HK1025907A1 (es)
HU (1) HU229641B1 (es)
IL (2) IL155799A (es)
IS (1) IS2087B (es)
LV (1) LV12492B (es)
ME (1) ME00530B (es)
NO (2) NO313983B1 (es)
NZ (2) NZ500149A (es)
OA (1) OA11169A (es)
PL (1) PL193275B1 (es)
PT (2) PT1222921E (es)
RO (1) RO120605B1 (es)
SI (1) SI20149B (es)
SK (2) SK283947B6 (es)
TR (1) TR199902733T2 (es)
UA (2) UA57079C2 (es)
WO (1) WO1998050035A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
CA2636527C (en) 2006-01-09 2016-05-17 Romark Laboratories, L.C. Viral hepatitis treatment
PL2395840T3 (pl) * 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
PE20121118A1 (es) 2009-05-12 2012-09-05 Romark Lab Lc Compuestos de haloalquil heteroaril benzamida
EP2445349B1 (en) 2009-06-26 2022-02-09 Romark Laboratories, L.C. Compounds and methods for treating influenza
US9498441B2 (en) 2012-01-27 2016-11-22 Siegfried Rhein S.A. De C.V. Nitazoxadine composition and process to prepare same
AU2015346413B2 (en) * 2014-11-11 2019-08-29 Romark Laboratories, L.C. Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
US11612567B2 (en) 2018-02-02 2023-03-28 Ripple Therapeutics Corporation Ocular inserts comprising a covalently linked steroid dimer
EP4146664A2 (en) 2020-05-01 2023-03-15 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
KR20040004544A (ko) 2004-01-13
UA57079C2 (uk) 2003-06-16
AU740022B2 (en) 2001-10-25
KR100576646B1 (ko) 2006-05-08
NO335781B1 (no) 2015-02-16
HK1025907A1 (en) 2000-12-01
DE69809928T2 (de) 2003-04-24
SK283947B6 (sk) 2004-05-04
EP1005342A4 (en) 2001-02-07
UA74388C2 (uk) 2005-12-15
GEP20032970B (en) 2003-05-27
IL155799A (en) 2004-08-31
SI20149B (en) 2001-08-31
NO20021832L (no) 2000-01-04
AU7289598A (en) 1998-11-27
NO20021832D0 (no) 2002-04-18
BR9808722A (pt) 2000-07-11
CA2288003A1 (en) 1998-11-12
CZ298270B6 (cs) 2007-08-08
IL155799A0 (en) 2003-12-23
JP2001503067A (ja) 2001-03-06
CA2418634A1 (en) 1998-11-12
CZ391199A3 (cs) 2000-07-12
SK283946B6 (sk) 2004-05-04
EA199901012A1 (ru) 2000-08-28
OA11169A (en) 2003-04-25
KR100426657B1 (ko) 2004-04-13
DE69809928D1 (de) 2003-01-16
ES2150404T3 (es) 2003-07-01
CN1255060A (zh) 2000-05-31
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
CN1552322A (zh) 2004-12-08
NO995406D0 (no) 1999-11-04
CN100515420C (zh) 2009-07-22
NZ500149A (en) 2001-11-30
AP1103A (en) 2002-09-04
EP1222921A1 (en) 2002-07-17
EA002920B1 (ru) 2002-10-31
BG109365A (en) 2006-08-31
SI20149A (sl) 2000-08-31
BG64973B1 (bg) 2006-11-30
PT1005342E (pt) 2003-02-28
DE69827417D1 (de) 2004-12-09
PT1222921E (pt) 2005-02-28
CZ298269B6 (cs) 2007-08-08
TR199902733T2 (xx) 2000-03-21
EP1222921B1 (en) 2004-11-03
SK151199A3 (en) 2000-07-11
ES2232687T3 (es) 2005-06-01
CA2288003C (en) 2003-10-21
LV12492B (en) 2001-01-20
DE69827417T2 (de) 2005-10-27
WO1998050035A1 (en) 1998-11-12
NZ513881A (en) 2002-10-25
EE04870B1 (et) 2007-08-15
EA200100956A1 (ru) 2002-02-28
NO995406L (no) 2000-01-04
EP1005342B1 (en) 2002-12-04
IL132516A (en) 2003-12-10
ES2150404T1 (es) 2000-12-01
IL132516A0 (en) 2001-03-19
RO120605B1 (ro) 2006-05-30
HUP0003330A2 (hu) 2001-05-28
IS5223A (is) 1999-10-19
CN1158074C (zh) 2004-07-21
JP3739802B2 (ja) 2006-01-25
ATE228839T1 (de) 2002-12-15
IS2087B (is) 2006-03-15
AR057242A2 (es) 2007-11-21
KR20010020322A (ko) 2001-03-15
BG103958A (en) 2000-07-31
HUP0003330A3 (en) 2002-10-28
NO313983B1 (no) 2003-01-13
HU229641B1 (en) 2014-03-28
EA002908B1 (ru) 2002-10-31
EP1005342A1 (en) 2000-06-07
EE9900578A (et) 2000-08-15
LV12492A (en) 2000-06-20
PL336805A1 (en) 2000-07-17
ME00530B (me) 2011-10-10
PL193275B1 (pl) 2007-01-31
ATE281166T1 (de) 2004-11-15
DK1222921T3 (da) 2005-03-07

Similar Documents

Publication Publication Date Title
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO20001914D0 (no) <alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
ZA983849B (en) Pharmaceutical compositions of tizoxanide and nitazoxanide.
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0101701A3 (en) Substituted betha-alanines and pharmaceutical compositions comprising them
BR9509688A (pt) Composto e composição farmacêutica
DK1005342T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ID23531A (id) Komposisi farmasi
BR9505130A (pt) Composto e composiçao farmacêutica
BR9605220A (pt) Gonadotropinas e composiçao farmacêutica
BR1100391A (pt) Composto e composição farmacêutica
SE9703737D0 (sv) Pharmaceutical composition and use
HUP0004274A3 (en) Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
BR1101151A (pt) Compostos e composição farmacêutica
BR1100838A (pt) Composto e composição farmacêutica
HUP0003827A2 (en) Cyanoamidine derivatives and pharmaceutical compositions containing them
BR1100755A (pt) composição farmacêutica
BR1100809A (pt) Composto e composição farmacêutica
BR1100293A (pt) Composto e composição farmacêutica
GB9721071D0 (en) Pharmaceutical compositions and their use